Deals In Depth: June 2018
Executive Summary
Sanofi teamed up with Translate Bio in an $850 million mRNA vaccine/infectious disease deal. Novartis spun off the device assets of Alcon through a share buyback program worth $5 billion. Strong showings from FOPOs and IPOs boosted biopharma financing to $5.2 billion.